 | • レポートコード：MRC2-11QY03293 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は双極性障害治療のグローバル市場について調査・分析したレポートです。種類別（抗精神病薬、抗けいれん薬、気分安定薬）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別双極性障害治療の競争状況、市場シェア ・世界の双極性障害治療市場：種類別市場規模 2015年-2020年（抗精神病薬、抗けいれん薬、気分安定薬） ・世界の双極性障害治療市場：種類別市場規模予測 2021年-2026年（抗精神病薬、抗けいれん薬、気分安定薬） ・世界の双極性障害治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の双極性障害治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の双極性障害治療市場分析：米国、カナダ ・ヨーロッパの双極性障害治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの双極性障害治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の双極性障害治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの双極性障害治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly、Bristol-Myers Squibb、AstraZeneca、Allergan、Astellas Pharma、GlaxoSmithKline、Janssen Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. According to Pfizer, Inc., bipolar disorder affects over 5 million people in the U.S. Bipolar episodes are characterized by a drastic change in behavior and mood, and range from joyful and overexcited (manic episodes) to extremely sad and hopeless (depressive state). These disorders have different types of episodes such as manic episodes, hypomanic episodes, depressive episodes, and mixed episodes. Causes of bipolar disorders include childhood trauma, stressful life events, self-esteem problems, and genetic inheritance. People across the world marked “March 30” as a World Bipolar Day to spread awareness about the disorder and erase the stigma of mental illness. Large number of people suffering from this mental condition resort to drinking to lift their mood. According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse.
The growing need to reduce the financial burden of bipolar disorder will drive the growth prospects for the global bipolar disorder therapeutic market until the end of 2021. It has been observed that governments and companies across the globe are increasingly organizing awareness camps to raise disease awareness among the public, reduce the burden of mental disorders in vulnerable groups, ensure the rights of people with mental disorders, and make treatment facilities accessible to them. Consequently, such awareness initiatives help to curb the overall monetary loss, reduce their effect on the global economy, and improve the quality of life for patients. Such factors will raise public awareness about mental disorders and treatments and in turn, propel the rate of revenue generation in the market.
Market Analysis and Insights: Global Bipolar Disorder Therapeutic Market
The global Bipolar Disorder Therapeutic market size is projected to reach US$ 3939.7 million by 2026, from US$ 3855.3 million in 2020, at a CAGR of 2.0%% during 2021-2026.
Global Bipolar Disorder Therapeutic Scope and Market Size
Bipolar Disorder Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bipolar Disorder Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bipolar Disorder Therapeutic market is segmented into
Antipsychotics
Anticonvulsants
Mood Stabilizers
Segment by Application, the Bipolar Disorder Therapeutic market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Bipolar Disorder Therapeutic market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bipolar Disorder Therapeutic market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bipolar Disorder Therapeutic Market Share Analysis
Bipolar Disorder Therapeutic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bipolar Disorder Therapeutic business, the date to enter into the Bipolar Disorder Therapeutic market, Bipolar Disorder Therapeutic product introduction, recent developments, etc.
The major vendors covered:
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
Astellas Pharma
GlaxoSmithKline
Janssen Pharmaceuticals
…
1 Study Coverage
1.1 Bipolar Disorder Therapeutic Product Introduction
1.2 Market Segments
1.3 Key Bipolar Disorder Therapeutic Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bipolar Disorder Therapeutic Market Size Growth Rate by Type
1.4.2 Antipsychotics
1.4.3 Anticonvulsants
1.4.4 Mood Stabilizers
1.5 Market by Application
1.5.1 Global Bipolar Disorder Therapeutic Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bipolar Disorder Therapeutic Market Size, Estimates and Forecasts
2.1.1 Global Bipolar Disorder Therapeutic Revenue 2015-2026
2.1.2 Global Bipolar Disorder Therapeutic Sales 2015-2026
2.2 Global Bipolar Disorder Therapeutic, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bipolar Disorder Therapeutic Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bipolar Disorder Therapeutic Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bipolar Disorder Therapeutic Competitor Landscape by Players
3.1 Bipolar Disorder Therapeutic Sales by Manufacturers
3.1.1 Bipolar Disorder Therapeutic Sales by Manufacturers (2015-2020)
3.1.2 Bipolar Disorder Therapeutic Sales Market Share by Manufacturers (2015-2020)
3.2 Bipolar Disorder Therapeutic Revenue by Manufacturers
3.2.1 Bipolar Disorder Therapeutic Revenue by Manufacturers (2015-2020)
3.2.2 Bipolar Disorder Therapeutic Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bipolar Disorder Therapeutic Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bipolar Disorder Therapeutic Revenue in 2019
3.2.5 Global Bipolar Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bipolar Disorder Therapeutic Price by Manufacturers
3.4 Bipolar Disorder Therapeutic Manufacturing Base Distribution, Product Types
3.4.1 Bipolar Disorder Therapeutic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bipolar Disorder Therapeutic Product Type
3.4.3 Date of International Manufacturers Enter into Bipolar Disorder Therapeutic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bipolar Disorder Therapeutic Market Size by Type (2015-2020)
4.1.1 Global Bipolar Disorder Therapeutic Sales by Type (2015-2020)
4.1.2 Global Bipolar Disorder Therapeutic Revenue by Type (2015-2020)
4.1.3 Bipolar Disorder Therapeutic Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bipolar Disorder Therapeutic Market Size Forecast by Type (2021-2026)
4.2.1 Global Bipolar Disorder Therapeutic Sales Forecast by Type (2021-2026)
4.2.2 Global Bipolar Disorder Therapeutic Revenue Forecast by Type (2021-2026)
4.2.3 Bipolar Disorder Therapeutic Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bipolar Disorder Therapeutic Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bipolar Disorder Therapeutic Market Size by Application (2015-2020)
5.1.1 Global Bipolar Disorder Therapeutic Sales by Application (2015-2020)
5.1.2 Global Bipolar Disorder Therapeutic Revenue by Application (2015-2020)
5.1.3 Bipolar Disorder Therapeutic Price by Application (2015-2020)
5.2 Bipolar Disorder Therapeutic Market Size Forecast by Application (2021-2026)
5.2.1 Global Bipolar Disorder Therapeutic Sales Forecast by Application (2021-2026)
5.2.2 Global Bipolar Disorder Therapeutic Revenue Forecast by Application (2021-2026)
5.2.3 Global Bipolar Disorder Therapeutic Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bipolar Disorder Therapeutic by Country
6.1.1 North America Bipolar Disorder Therapeutic Sales by Country
6.1.2 North America Bipolar Disorder Therapeutic Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bipolar Disorder Therapeutic Market Facts & Figures by Type
6.3 North America Bipolar Disorder Therapeutic Market Facts & Figures by Application
7 Europe
7.1 Europe Bipolar Disorder Therapeutic by Country
7.1.1 Europe Bipolar Disorder Therapeutic Sales by Country
7.1.2 Europe Bipolar Disorder Therapeutic Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bipolar Disorder Therapeutic Market Facts & Figures by Type
7.3 Europe Bipolar Disorder Therapeutic Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bipolar Disorder Therapeutic by Region
8.1.1 Asia Pacific Bipolar Disorder Therapeutic Sales by Region
8.1.2 Asia Pacific Bipolar Disorder Therapeutic Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bipolar Disorder Therapeutic Market Facts & Figures by Type
8.3 Asia Pacific Bipolar Disorder Therapeutic Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bipolar Disorder Therapeutic by Country
9.1.1 Latin America Bipolar Disorder Therapeutic Sales by Country
9.1.2 Latin America Bipolar Disorder Therapeutic Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bipolar Disorder Therapeutic Market Facts & Figures by Type
9.3 Central & South America Bipolar Disorder Therapeutic Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bipolar Disorder Therapeutic by Country
10.1.1 Middle East and Africa Bipolar Disorder Therapeutic Sales by Country
10.1.2 Middle East and Africa Bipolar Disorder Therapeutic Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bipolar Disorder Therapeutic Market Facts & Figures by Type
10.3 Middle East and Africa Bipolar Disorder Therapeutic Market Facts & Figures by Application
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description and Business Overview
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Bipolar Disorder Therapeutic Products Offered
11.1.5 Eli Lilly Related Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Description and Business Overview
11.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Bipolar Disorder Therapeutic Products Offered
11.2.5 Bristol-Myers Squibb Related Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Description and Business Overview
11.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AstraZeneca Bipolar Disorder Therapeutic Products Offered
11.3.5 AstraZeneca Related Developments
11.4 Allergan
11.4.1 Allergan Corporation Information
11.4.2 Allergan Description and Business Overview
11.4.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Allergan Bipolar Disorder Therapeutic Products Offered
11.4.5 Allergan Related Developments
11.5 Astellas Pharma
11.5.1 Astellas Pharma Corporation Information
11.5.2 Astellas Pharma Description and Business Overview
11.5.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Astellas Pharma Bipolar Disorder Therapeutic Products Offered
11.5.5 Astellas Pharma Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Bipolar Disorder Therapeutic Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 Janssen Pharmaceuticals
11.7.1 Janssen Pharmaceuticals Corporation Information
11.7.2 Janssen Pharmaceuticals Description and Business Overview
11.7.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Products Offered
11.7.5 Janssen Pharmaceuticals Related Developments
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description and Business Overview
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Bipolar Disorder Therapeutic Products Offered
11.1.5 Eli Lilly Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bipolar Disorder Therapeutic Market Estimates and Projections by Region
12.1.1 Global Bipolar Disorder Therapeutic Sales Forecast by Regions 2021-2026
12.1.2 Global Bipolar Disorder Therapeutic Revenue Forecast by Regions 2021-2026
12.2 North America Bipolar Disorder Therapeutic Market Size Forecast (2021-2026)
12.2.1 North America: Bipolar Disorder Therapeutic Sales Forecast (2021-2026)
12.2.2 North America: Bipolar Disorder Therapeutic Revenue Forecast (2021-2026)
12.2.3 North America: Bipolar Disorder Therapeutic Market Size Forecast by Country (2021-2026)
12.3 Europe Bipolar Disorder Therapeutic Market Size Forecast (2021-2026)
12.3.1 Europe: Bipolar Disorder Therapeutic Sales Forecast (2021-2026)
12.3.2 Europe: Bipolar Disorder Therapeutic Revenue Forecast (2021-2026)
12.3.3 Europe: Bipolar Disorder Therapeutic Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bipolar Disorder Therapeutic Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bipolar Disorder Therapeutic Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bipolar Disorder Therapeutic Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bipolar Disorder Therapeutic Market Size Forecast by Region (2021-2026)
12.5 Latin America Bipolar Disorder Therapeutic Market Size Forecast (2021-2026)
12.5.1 Latin America: Bipolar Disorder Therapeutic Sales Forecast (2021-2026)
12.5.2 Latin America: Bipolar Disorder Therapeutic Revenue Forecast (2021-2026)
12.5.3 Latin America: Bipolar Disorder Therapeutic Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bipolar Disorder Therapeutic Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bipolar Disorder Therapeutic Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bipolar Disorder Therapeutic Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bipolar Disorder Therapeutic Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bipolar Disorder Therapeutic Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bipolar Disorder Therapeutic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Bipolar Disorder Therapeutic Market Segments
Table 2. Ranking of Global Top Bipolar Disorder Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bipolar Disorder Therapeutic Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Antipsychotics
Table 5. Major Manufacturers of Anticonvulsants
Table 6. Major Manufacturers of Mood Stabilizers
Table 7. Global Bipolar Disorder Therapeutic Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Bipolar Disorder Therapeutic Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Bipolar Disorder Therapeutic Sales by Regions 2015-2020 (K MT)
Table 10. Global Bipolar Disorder Therapeutic Sales Market Share by Regions (2015-2020)
Table 11. Global Bipolar Disorder Therapeutic Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Bipolar Disorder Therapeutic Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Bipolar Disorder Therapeutic Sales Share by Manufacturers (2015-2020)
Table 14. Global Bipolar Disorder Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Bipolar Disorder Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder Therapeutic as of 2019)
Table 16. Bipolar Disorder Therapeutic Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Bipolar Disorder Therapeutic Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Bipolar Disorder Therapeutic Price (2015-2020) (USD/MT)
Table 19. Bipolar Disorder Therapeutic Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Bipolar Disorder Therapeutic Product Type
Table 21. Date of International Manufacturers Enter into Bipolar Disorder Therapeutic Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Bipolar Disorder Therapeutic Sales by Type (2015-2020) (K MT)
Table 24. Global Bipolar Disorder Therapeutic Sales Share by Type (2015-2020)
Table 25. Global Bipolar Disorder Therapeutic Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Bipolar Disorder Therapeutic Revenue Share by Type (2015-2020)
Table 27. Bipolar Disorder Therapeutic Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Bipolar Disorder Therapeutic Sales by Application (2015-2020) (K MT)
Table 29. Global Bipolar Disorder Therapeutic Sales Share by Application (2015-2020)
Table 30. North America Bipolar Disorder Therapeutic Sales by Country (2015-2020) (K MT)
Table 31. North America Bipolar Disorder Therapeutic Sales Market Share by Country (2015-2020)
Table 32. North America Bipolar Disorder Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Bipolar Disorder Therapeutic Revenue Market Share by Country (2015-2020)
Table 34. North America Bipolar Disorder Therapeutic Sales by Type (2015-2020) (K MT)
Table 35. North America Bipolar Disorder Therapeutic Sales Market Share by Type (2015-2020)
Table 36. North America Bipolar Disorder Therapeutic Sales by Application (2015-2020) (K MT)
Table 37. North America Bipolar Disorder Therapeutic Sales Market Share by Application (2015-2020)
Table 38. Europe Bipolar Disorder Therapeutic Sales by Country (2015-2020) (K MT)
Table 39. Europe Bipolar Disorder Therapeutic Sales Market Share by Country (2015-2020)
Table 40. Europe Bipolar Disorder Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Bipolar Disorder Therapeutic Revenue Market Share by Country (2015-2020)
Table 42. Europe Bipolar Disorder Therapeutic Sales by Type (2015-2020) (K MT)
Table 43. Europe Bipolar Disorder Therapeutic Sales Market Share by Type (2015-2020)
Table 44. Europe Bipolar Disorder Therapeutic Sales by Application (2015-2020) (K MT)
Table 45. Europe Bipolar Disorder Therapeutic Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Bipolar Disorder Therapeutic Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Bipolar Disorder Therapeutic Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Bipolar Disorder Therapeutic Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Bipolar Disorder Therapeutic Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Bipolar Disorder Therapeutic Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Bipolar Disorder Therapeutic Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Bipolar Disorder Therapeutic Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Bipolar Disorder Therapeutic Sales Market Share by Application (2015-2020)
Table 54. Latin America Bipolar Disorder Therapeutic Sales by Country (2015-2020) (K MT)
Table 55. Latin America Bipolar Disorder Therapeutic Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Bipolar Disorder Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Bipolar Disorder Therapeutic Revenue Market Share by Country (2015-2020)
Table 58. Latin America Bipolar Disorder Therapeutic Sales by Type (2015-2020) (K MT)
Table 59. Latin America Bipolar Disorder Therapeutic Sales Market Share by Type (2015-2020)
Table 60. Latin America Bipolar Disorder Therapeutic Sales by Application (2015-2020) (K MT)
Table 61. Latin America Bipolar Disorder Therapeutic Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Bipolar Disorder Therapeutic Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Bipolar Disorder Therapeutic Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Bipolar Disorder Therapeutic Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Bipolar Disorder Therapeutic Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Bipolar Disorder Therapeutic Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Bipolar Disorder Therapeutic Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Bipolar Disorder Therapeutic Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Bipolar Disorder Therapeutic Sales Market Share by Application (2015-2020)
Table 70. Eli Lilly Corporation Information
Table 71. Eli Lilly Description and Major Businesses
Table 72. Eli Lilly Bipolar Disorder Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Eli Lilly Product
Table 74. Eli Lilly Recent Development
Table 75. Bristol-Myers Squibb Corporation Information
Table 76. Bristol-Myers Squibb Description and Major Businesses
Table 77. Bristol-Myers Squibb Bipolar Disorder Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bristol-Myers Squibb Product
Table 79. Bristol-Myers Squibb Recent Development
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Major Businesses
Table 82. AstraZeneca Bipolar Disorder Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. AstraZeneca Product
Table 84. AstraZeneca Recent Development
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Major Businesses
Table 87. Allergan Bipolar Disorder Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Allergan Product
Table 89. Allergan Recent Development
Table 90. Astellas Pharma Corporation Information
Table 91. Astellas Pharma Description and Major Businesses
Table 92. Astellas Pharma Bipolar Disorder Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Astellas Pharma Product
Table 94. Astellas Pharma Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Major Businesses
Table 97. GlaxoSmithKline Bipolar Disorder Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Janssen Pharmaceuticals Corporation Information
Table 101. Janssen Pharmaceuticals Description and Major Businesses
Table 102. Janssen Pharmaceuticals Bipolar Disorder Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Janssen Pharmaceuticals Product
Table 104. Janssen Pharmaceuticals Recent Development
Table 105. Global Bipolar Disorder Therapeutic Sales Forecast by Regions (2021-2026) (K MT)
Table 106. Global Bipolar Disorder Therapeutic Sales Market Share Forecast by Regions (2021-2026)
Table 107. Global Bipolar Disorder Therapeutic Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 108. Global Bipolar Disorder Therapeutic Revenue Market Share Forecast by Regions (2021-2026)
Table 109. North America: Bipolar Disorder Therapeutic Sales Forecast by Country (2021-2026) (K MT)
Table 110. North America: Bipolar Disorder Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Europe: Bipolar Disorder Therapeutic Sales Forecast by Country (2021-2026) (K MT)
Table 112. Europe: Bipolar Disorder Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Asia Pacific: Bipolar Disorder Therapeutic Sales Forecast by Region (2021-2026) (K MT)
Table 114. Asia Pacific: Bipolar Disorder Therapeutic Revenue Forecast by Region (2021-2026) (US$ Million)
Table 115. Latin America: Bipolar Disorder Therapeutic Sales Forecast by Country (2021-2026) (K MT)
Table 116. Latin America: Bipolar Disorder Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Middle East and Africa: Bipolar Disorder Therapeutic Sales Forecast by Country (2021-2026) (K MT)
Table 118. Middle East and Africa: Bipolar Disorder Therapeutic Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 120. Key Challenges
Table 121. Market Risks
Table 122. Main Points Interviewed from Key Bipolar Disorder Therapeutic Players
Table 123. Bipolar Disorder Therapeutic Customers List
Table 124. Bipolar Disorder Therapeutic Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Bipolar Disorder Therapeutic Product Picture
Figure 2. Global Bipolar Disorder Therapeutic Sales Market Share by Type in 2020 & 2026
Figure 3. Antipsychotics Product Picture
Figure 4. Anticonvulsants Product Picture
Figure 5. Mood Stabilizers Product Picture
Figure 6. Global Bipolar Disorder Therapeutic Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Bipolar Disorder Therapeutic Report Years Considered
Figure 11. Global Bipolar Disorder Therapeutic Market Size 2015-2026 (US$ Million)
Figure 12. Global Bipolar Disorder Therapeutic Sales 2015-2026 (K MT)
Figure 13. Global Bipolar Disorder Therapeutic Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Bipolar Disorder Therapeutic Sales Market Share by Region (2015-2020)
Figure 15. Global Bipolar Disorder Therapeutic Sales Market Share by Region in 2019
Figure 16. Global Bipolar Disorder Therapeutic Revenue Market Share by Region (2015-2020)
Figure 17. Global Bipolar Disorder Therapeutic Revenue Market Share by Region in 2019
Figure 18. Global Bipolar Disorder Therapeutic Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Bipolar Disorder Therapeutic Revenue in 2019
Figure 20. Bipolar Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Bipolar Disorder Therapeutic Sales Market Share by Type (2015-2020)
Figure 22. Global Bipolar Disorder Therapeutic Sales Market Share by Type in 2019
Figure 23. Global Bipolar Disorder Therapeutic Revenue Market Share by Type (2015-2020)
Figure 24. Global Bipolar Disorder Therapeutic Revenue Market Share by Type in 2019
Figure 25. Global Bipolar Disorder Therapeutic Market Share by Price Range (2015-2020)
Figure 26. Global Bipolar Disorder Therapeutic Sales Market Share by Application (2015-2020)
Figure 27. Global Bipolar Disorder Therapeutic Sales Market Share by Application in 2019
Figure 28. Global Bipolar Disorder Therapeutic Revenue Market Share by Application (2015-2020)
Figure 29. Global Bipolar Disorder Therapeutic Revenue Market Share by Application in 2019
Figure 30. North America Bipolar Disorder Therapeutic Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Bipolar Disorder Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Bipolar Disorder Therapeutic Sales Market Share by Country in 2019
Figure 33. North America Bipolar Disorder Therapeutic Revenue Market Share by Country in 2019
Figure 34. U.S. Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Bipolar Disorder Therapeutic Market Share by Type in 2019
Figure 39. North America Bipolar Disorder Therapeutic Market Share by Application in 2019
Figure 40. Europe Bipolar Disorder Therapeutic Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Bipolar Disorder Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Bipolar Disorder Therapeutic Sales Market Share by Country in 2019
Figure 43. Europe Bipolar Disorder Therapeutic Revenue Market Share by Country in 2019
Figure 44. Germany Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Bipolar Disorder Therapeutic Market Share by Type in 2019
Figure 55. Europe Bipolar Disorder Therapeutic Market Share by Application in 2019
Figure 56. Asia Pacific Bipolar Disorder Therapeutic Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Bipolar Disorder Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Bipolar Disorder Therapeutic Sales Market Share by Region in 2019
Figure 59. Asia Pacific Bipolar Disorder Therapeutic Revenue Market Share by Region in 2019
Figure 60. China Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Bipolar Disorder Therapeutic Market Share by Type in 2019
Figure 83. Asia Pacific Bipolar Disorder Therapeutic Market Share by Application in 2019
Figure 84. Latin America Bipolar Disorder Therapeutic Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Bipolar Disorder Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Bipolar Disorder Therapeutic Sales Market Share by Country in 2019
Figure 87. Latin America Bipolar Disorder Therapeutic Revenue Market Share by Country in 2019
Figure 88. Mexico Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Bipolar Disorder Therapeutic Market Share by Type in 2019
Figure 95. Latin America Bipolar Disorder Therapeutic Market Share by Application in 2019
Figure 96. Middle East and Africa Bipolar Disorder Therapeutic Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Bipolar Disorder Therapeutic Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Bipolar Disorder Therapeutic Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Bipolar Disorder Therapeutic Revenue Market Share by Country in 2019
Figure 100. Turkey Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Bipolar Disorder Therapeutic Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Bipolar Disorder Therapeutic Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Bipolar Disorder Therapeutic Market Share by Type in 2019
Figure 107. Middle East and Africa Bipolar Disorder Therapeutic Market Share by Application in 2019
Figure 108. North America Bipolar Disorder Therapeutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Bipolar Disorder Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Bipolar Disorder Therapeutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Bipolar Disorder Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Bipolar Disorder Therapeutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Bipolar Disorder Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Bipolar Disorder Therapeutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Bipolar Disorder Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Bipolar Disorder Therapeutic Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Bipolar Disorder Therapeutic Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
色素沈着障害治療の世界市場（～2026年） Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color. Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, phototherapy, and laser therapy. These therapies are availabl…- 糖尿病性神経障害治療薬の世界市場（～2026年） A drug used to treat mental illness caused by diabetes Market Analysis and Insights: Global Diabetic Neurological Disorder Therapeutic Drug Market The global Diabetic Neurological Disorder Therapeutic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CA…
- 燃料電池バイポーラ板の世界市場（～2026年） Market Analysis and Insights: Global Fuel Cell Bipolar Plates Market The global Fuel Cell Bipolar Plates market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Fuel Cell Bipolar Plates Scope and Market Size Fuel Cell Bipolar …
- 睡眠障害治療薬の世界市場（～2026年） Sleep disorders result in a lack of deep and restorative sleep. The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. Market Analysis and Insights: Global Sleep Disorder Therapeutics …
- 双極性障害治療薬の世界市場（～2026年） Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. Rise in prevalence of bipolar disorder, high…